Skip to content

Clinical trials

Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Clear all

638 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20035
20041
20056
20065
20079
200810
20097
20109
201111
201214
201319
201423
201513
201628
201731
201825
201931
202048
202145
202239
202366
202454
202549
202675

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed240
Recruiting145
Unknown status120
Not yet recruiting47
Terminated36
Active, not recruiting28
Enrolling by invitation9
Withdrawn6
Suspended3
Available2
No longer available1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim23
Assiut University15
Assistance Publique - Hôpitaux de Paris8
Post Graduate Institute of Medical Education and Research, Chandigarh8
United Therapeutics8
Celgene7
Duke University7
Aveiro University6
Gazi University6
GlaxoSmithKline6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial638
Idiopathic Pulmonary Fibrosis102
Pulmonary Fibrosis94
Pulmonary Disease, Chronic Obstructive88
Hypertension, Pulmonary47
Lung Diseases40
Scleroderma, Systemic39
Arthritis, Rheumatoid37
Connective Tissue Diseases30
Asthma29

Trials

Showing 76 to 100 of 638. Each trial links to its page on Pharma Observatory.

538 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.